脑部放疗，上午比下午敏感许多！
2 U8 a3 y, y! ]* n4 h" z- {* N5 p8 w( Z
# h, m( i9 t+ W* v) BCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.( Y7 P4 ?) ?. e
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
( J. Q: w w4 y4 i# {Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.' n7 A! S) I8 B% N; Z2 l" ^4 {
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
4 V6 |2 U5 m1 x; ~9 u6 Y7 s/ C
- j+ J, T6 F( g3 d/ @# R! jAbstract3 G; o5 K V1 Z% m; f8 D
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.; ?/ e* Y, i4 n( R. X" F) a
5 M8 W, A y! X+ Y& g, e
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.4 e5 n- O, V1 H7 Y9 k# y; m
- c- n( N& {3 F8 j. M+ MRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).; o1 _% ^6 d- t7 C. D
) J& H+ g2 R! B% ]8 Q/ b/ m
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
, _/ A( I4 ^: ^8 t1 x. Z" A
% g6 R/ Z& Y6 M$ k' j |
显身卡
